BioCentury
ARTICLE | Company News

Celltech Chiroscience, Medeva deal

November 15, 1999 8:00 AM UTC

CCH will acquire MDV for £563 million ($912 million) in a stock swap of 34 newly issued CCH shares for every 100 MDV shares, valuing each MDV share at 165p ($2.67), a 16 percent premium to MDV’s value...